Dimensional Fund Advisors
IMVT icon

Dimensional Fund Advisors’s Immunovant IMVT Stock Holding History

Dimensional Fund Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Sell
55,528
-1,558
-3% -$47.5K ﹤0.01% 2729
2026
Q1 		$1.42M Sell
57,086
-103,356
-64% -$2.68M ﹤0.01% 2773
2025
Q4 		$4.08M Sell
160,442
-213,843
-57% -$4.77M ﹤0.01% 2583
2025
Q3 		$6.03M Buy
374,285
+137,319
+58% +$2.22M ﹤0.01% 2486
2025
Q2 		$3.79M Sell
236,966
-157,970
-40% -$2.39M ﹤0.01% 2600
2025
Q1 		$6.75M Sell
394,936
-8,811
-2% -$184K ﹤0.01% 2403
2024
Q4 		$10M Sell
403,747
-58,463
-13% -$1.66M ﹤0.01% 2305
2024
Q3 		$13.2M Sell
462,210
-32,479
-7% -$958K ﹤0.01% 2187
2024
Q2 		$13.1M Sell
494,689
-78,758
-14% -$2.24M ﹤0.01% 2143
2024
Q1 		$18.5M Sell
573,447
-138,503
-19% -$5.05M 0.01% 2026
2023
Q4 		$30M Sell
711,950
-24,579
-3% -$904K 0.01% 1769
2023
Q3 		$28.3M Sell
736,529
-134,168
-15% -$3.03M 0.01% 1726
2023
Q2 		$16.5M Sell
870,697
-161,266
-16% -$3.01M 0.01% 2027
2023
Q1 		$16M Buy
+1,031,963
New +$17.9M 0.01% 2012
2022
Q3 		$5.91M Buy
1,058,459
+112,979
+12% +$552K ﹤0.01% 2372
2022
Q2 		$3.69M Buy
945,480
+254,515
+37% +$1.1M ﹤0.01% 2543
2022
Q1 		$3.81M Buy
690,965
+412,997
+149% +$2.57M ﹤0.01% 2617
2021
Q4 		$2.37M Buy
277,968
+264,230
+1,923% +$2.18M ﹤0.01% 2804
2021
Q3 		$119K Buy
+13,738
New +$124K ﹤0.01% 3408

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors's IMVT Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Immunovant (IMVT) stake by 2.7% in Q2 2026, selling an estimated $47.5K and leaving 55,528 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2729.

Dimensional Fund Advisors first reported a position in IMVT in Q3 2021 and has held it in 19 quarters since. The position peaked at $30M in Q4 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Dimensional Fund Advisors held 55,528 shares of Immunovant worth $2.14M as of Q2 2026.
  • Dimensional Fund Advisors sold 1,558 Immunovant shares in Q2 2026, an estimated $47.5K.
  • Immunovant made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2729 holding.
  • Dimensional Fund Advisors first reported a position in Immunovant in Q3 2021 and has held it in 19 quarters since.
  • Dimensional Fund Advisors's Immunovant position peaked at $30M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.